Home » dupilumab

dupilumab

ORIGINAL ARTICLE
Experience with dupilumab in patients with atopic dermatitis
01.8k.
E. A. Glukhova, E. D. Kuvshinova, V. A. Revyakina
ALLERGOLOGY and IMMUNOLOGY in PEDIATRICS
REVIEW
The application of the biological treatment in atopic dermatitis: focus on dupilumab
02k.
ALLERGOLOGY and IMMUNOLOGY in PEDIATRICS
Registration certificate

Certificate number: ПИ № 77 – 17742

Registration date: 09.03.2004

Certificate status: active

Media name:
«Allergology and Immunology in Pediatrics»

Founders:
Association of Pediatric Allergists and
Immunologists of Russia (APAIR)

6 Ostrovityanova Str., Moscow, 117513, Russia

Languages: Russian

The publication is included in the list of the Higher Attestation Commission

The journal is included into The list of leading 
peer-reviewed scientific journals and publications,
in which the publication of the main
results of dissertation research on
competition for the academic degree of candidate
and doctor of sciences.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Publisher, contacts

The journal is the official publication body of the
Association of Paediatric Allergists and Immunologists of Russia (APAIR),
All-Russian Public Organization.
Executive Director: Yuriy S. Smolkin.
Publisher Address: 6 Ostrovityanova Str., Moscow, 117513, Russia
Phone: 8(495) 225-7104, 8(495) 225-7107
Fax: 8(495) 225-7107
E-mail: adair@adair.ru

2020 - 2026 ®АЛЛЕРГОЛОГИЯ И ИММУНОЛОГИЯ В ПЕДИАТРИИ | Website created and supported by Syhanoff